SLC6A3 rs28362691: Stress Response and Dopamine Transport
The rs28362691 polymorphism is a single nucleotide variant located within the SLC6A3 gene, which encodes the human dopamine active transporter (DAT). Researchers study this variant as an informative tag SNP associated with differences in dopamine clearance and neurobiological responses during acute cognitive and psychological stress challenges. Current clinical evidence remains limited, meaning this marker reflects broad population-level patterns rather than a direct predictor of individual mental health or performance.
What each genotype means
Typical dopamine transporter expression
You carry two copies of the common A allele in the SLC6A3 gene. In research studies examining acute cognitive and psychological stress, this baseline genotype is associated with standard regulation of the dopamine active transporter. Because scientific evidence linking this specific tag variant directly to functional stress reactivity is limited and indirect, it should not be viewed as an indicator of your overall stress tolerance or mental health.
Found in approximately 55% of individuals of European ancestry and is the predominant genotype across global populations.
Intermediate stress-related dopamine response
You carry one copy of the G allele alongside the typical A allele. Some preliminary research associates the G allele with subtle differences in dopamine transporter availability during acute cognitive or psychological stress challenges. However, scientific evidence for this specific tag marker is limited, and this genetic finding does not diagnose any condition or imply an altered psychological resilience.
Carried by approximately 38% to 40% of people of European ancestry.
Altered dopamine transporter dynamics
You carry two copies of the less common G allele at this locus in the SLC6A3 gene. In preliminary neurobiological studies, this genotype has been evaluated as a tag variant correlated with altered dopamine transporter dynamics under acute mental stress tasks. Published evidence remains limited and observational, meaning this genotype does not determine clinical stress vulnerability or cognitive performance.
Present in roughly 7% of individuals of European descent and is relatively uncommon in most global ancestries.
Genomic Location and the SLC6A3 Gene
The single nucleotide polymorphism rs28362691 is situated on chromosome 5 within the SLC6A3 gene, formerly often referred to as DAT1. This gene is responsible for providing the molecular template to produce the dopamine transporter, an essential membrane-bound protein located on presynaptic dopaminergic neurons. As a tag SNP, rs28362691 frequently co-segregates with specific regulatory segments and complex structural elements, such as variable number tandem repeats (VNTRs), found across the wider SLC6A3 locus. The transporter serves as the primary molecular gatekeeper governing how long dopamine remains active in the synaptic cleft after neuronal firing.
Biological Role in Dopamine Dynamics
Dopamine is a critical central neurotransmitter involved in executive functioning, working memory, reward evaluation, and physiological reactions to acute demands. According to MedlinePlus Genetics, the dopamine transporter rapidly shuttles released dopamine out of the synaptic cleft back into the presynaptic neuron for recycling or breakdown. The rate and efficiency of this reuptake process dictate the amplitude and duration of post-synaptic signaling. When dopamine clearance fluctuates due to differences in transporter availability, brain networks regulating attention and emotional arousal can exhibit modest shifts in sensitivity, particularly when individuals are placed under demanding tasks.
Stress Response and Scientific Evidence
Genetic association studies have explored rs28362691 in relation to cognitive task performance, emotional reactivity, and physiological stress responses. Emerging models suggest that subtle expression differences in dopamine active transporters can modulate how prefrontal and striatal networks process acute stressors. However, evidence connecting rs28362691 specifically to human stress phenotypes is categorized as limited. Much of the underlying dopamine transporter literature centers on broader structural variations, such as the 3-prime UTR 40-base pair repeat, and findings across candidate gene studies frequently display mixed replication when tested in large, unbiased genome-wide association studies (GWAS).
Allele Distribution Across Populations
Allele frequencies for rs28362691 show measurable variation across distinct global ancestral groups. According to population genetic repositories including gnomAD, the minor allele frequency is approximately 0.26 in European populations, making both heterozygous and homozygous genotypes common in everyday cohorts. Frequencies in other continental groups vary, reflecting evolutionary divergence, recombination hotspots, and differing background linkage disequilibrium patterns across the SLC6A3 region. Because background genetic architecture differs between populations, statistical correlations identified in one ancestry group cannot be assumed to carry the exact same magnitude of association in others.
How to Interpret Your Genetic Data
Consumer genetic data for rs28362691 should be viewed purely as educational insight into baseline biological variation, not as a diagnostic test. Carrying a particular genotype does not make an individual inherently vulnerable or resilient to psychological stress, burnout, or attentional challenges. Human stress adaptation is a complex trait governed by hundreds of interacting genetic loci, life experiences, lifestyle routines, and coping mechanisms. Furthermore, while the dopamine transporter is targeted by various psychiatric medications and stimulants, genotype data for rs28362691 should never be used to alter medical therapies; any medication questions must be discussed directly with a qualified healthcare provider.
How common is this variant?
The minor allele frequency for rs28362691 is approximately 0.26 in European populations based on gnomAD, with varying frequencies observed across other continental ancestries.
Frequently asked questions
Does my rs28362691 genotype mean I handle stress poorly?
No. Stress reactivity is an intricate biological process driven by environmental circumstances, personal habits, psychological support, and countless genetic variants. While rs28362691 has been studied for subtle differences in dopamine transport, its individual impact is minimal and non-deterministic.
Is rs28362691 linked to ADHD or psychiatric conditions?
Although the SLC6A3 gene itself is widely studied in neurodevelopmental conditions such as ADHD, large-scale genome-wide association studies have not confirmed rs28362691 as a primary causal risk variant. Most clinical genetic associations in SLC6A3 are attributed to complex tandem repeats or rare coding mutations.
Can this variant help predict my response to ADHD or stimulant medications?
No, rs28362691 is not an established pharmacogenomic marker and is not recognized by clinical guidelines such as CPIC for drug selection. Anyone considering starting, stopping, or adjusting prescription medications must consult their physician or clinical pharmacist.
Why is the evidence for rs28362691 rated as limited?
The rating is considered limited because most reported links come from smaller candidate gene experiments or postmortem expression studies rather than massive, replicated genome-wide association studies. Many initial findings regarding dopamine candidate genes fail to show uniform effects across diverse ancestries.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs28362691?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SLC6A3
This variant in the dopamine transporter gene is linked to neuro-reproductive behavioral traits.
This variant in the dopamine transporter gene is studied for its potential influence on methylphenidate treatment response.
This SNP is part of a haplotype associated with treatment failure in patients receiving methylphenidate therapy.
Variant in the dopamine transporter gene (SLC6A3) associated with methylphenidate response in ADHD patients.
This variant in the dopamine transporter gene is linked to various behavioral and psychiatric traits.